Search | IOVS | ARVO Journals

Showing 1 – 20 of 44

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Radial foveal incisions as a surgical technique for persistent macula holes

Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5789. doi:

ARVO Annual Meeting Abstract July 2019

Microvascular abnormalities, retinal thickness changes and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD

Katja Hatz; Frank Zimmermann; Emmanouil Lazaridis; Dimitrios Kardamakis; Magdalena Guichard; Cengiz Tuerksever; Christian Pruente; Ursula Schmidt-Erfurth; Bianca S Gerendas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1154. doi:

ARVO Annual Meeting Abstract June 2017

Early retinal changes in Optical Coherence Tomography in patients with type 1 diabetes under intensified insulin therapy

Christian Pruente; Bianca S Gerendas; Katja B Hatz; Ursula Schmidt-Erfurth; Alessio Montuoro; Alexandra Kaider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):71. doi:

ARVO Annual Meeting Abstract June 2017

Correlation of total HbA1c load with prevalence of diabetic retinopathy among type 1 diabetic patients treated with intensified insulin therapy from the onset of disease

Katja B Hatz; Henryk Zulewski; Bianca S Gerendas; Anna Minder; Ursula Schmidt-Erfurth; Roger Lehmann; Alexandra Kaider; Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):82. doi:

ARVO Annual Meeting Abstract September 2016

Low energy stereotactic radiotherapy in combination with an anti VEGF treat and extend regimen for treatment of neovascular age related macular degeneration: 12 month outcomes

Katja B Hatz; Frank Zimmermann; Dimitrios Kardamakis; Emmanouil Lazaridis; Cengiz Tuerksever; Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3692. doi:

ARVO Annual Meeting Abstract June 2015

A cross sectional study assessing the prevalence of different stages of diabetic retinopathy and diabetic macular edema among type 1 diabetic patients treated with long-term intensified insulin therapy aiming near-normal blood glucose levels

Christian Pruente; Hendryk Zulewski; Ursula Schmidt-Erfurth; Bianca S. Gerendas; Katja B Hatz

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1452. doi:

ARVO Annual Meeting Abstract June 2015

Assessment of drusen and other retinal degenerative changes in patients with hereditary hemochromatosis

Moreno Menghini; Christian Pruente; Pierre Alexandre Krayenbuehl; Albina Nowak

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4220. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial

Katja B Hatz; Christian Pruente; Vistaklinik Binningen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4595. doi:

ARVO Annual Meeting Abstract April 2014

Efficacy and safety of ranibizumab in two treat-and-extend versus pro-re-nata regimes in patients with visual impairment due to diabetic macular edema: 24-month results of RETAIN study

Christian Pruente; RETAIN Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1700. doi:

ARVO Annual Meeting Abstract April 2014

Treat and Extend regimen versus Pro Re Nata regimen in a comparative study of ranibizumab in exudative age-related macular degeneration: 12 months results

Katja B Hatz; Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3931. doi:

ARVO Annual Meeting Abstract June 2013

Changing from pro re nata treatment regimen to a treat and extend regimen in neovascular age-related macular degeneration

Katja Hatz; Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3812. doi:

ARVO Annual Meeting Abstract March 2012

Prevalence Of Polypoidal Choroidal Vasculopathy Among Caucasian Bad-responders To Antivegf-treatment In Exudative Amd

Katja B. Hatz; Christian Pruente

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3805. doi:

Retina May 2011

Response of Retinal Vessels and Retrobulbar Hemodynamics to Intravitreal Anti-VEGF Treatment in Eyes with Branch Retinal Vein Occlusion

PDF

Stefan Sacu; Berthold Pemp; Günther Weigert; Gerlinde Matt; Gerhard Garhofer; Christian Pruente; Leopold Schmetterer; Ursula Schmidt-Erfurth
TAGS: anti-vascular endothelial growth factor therapy, eye, hemodynamics, ranibizumab, retinal vessels, venous retinal branch occlusion, edema, visual acuity, doppler color flow, doppler echocardiography
Invest. Ophthalmol. Vis. Sci.. 2011; 52(6):3046-3050. doi: https://doi.org/10.1167/iovs.10-5842

ARVO Annual Meeting Abstract April 2011

Effect of Intravitreal Anti-VEGF Therapy to Retinal Nonperfusion in Patients treated with Lucentis (Ranibizumab) for Retinal Vein Occlusion

Florian Weisskopf; Christian Pruente; Katja Hatz

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1256. doi:

ARVO Annual Meeting Abstract April 2011

Effect of Systemic Steroid after Successful Macular Surgery in Eyes with Epiretinal Membrane : Long Term Results of a Randomized Study

Markus Ritter; Stefan Sacu; Gerlinde Matt; Roman Dunavoelgyi; Wolf Buehl; Christian Pruente; Ursula Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2142. doi:

ARVO Annual Meeting Abstract April 2011

Ranibizumab Treatment for Diabetic Macular Edema in a Clinical Routine Setting: 12 Months Results

Christian Pruente; Katja Hatz

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):563. doi:

ARVO Annual Meeting Abstract April 2010

Response of Retinal Vessels to Anti Vascular Endothelial Growth Factor Treatment in Patients With Branch Retinal Vein Occlusion

C. Pruente; S. Sacu; B. Pemp; G. Matt; G. Weigert; G. Garhöfer; U. Schmidt-Erfurth; L. Schmetterer

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3567. doi:

ARVO Annual Meeting Abstract April 2010

Intravitreal Ranibizumab for the Treatment of Significant Macular Edema Secondary to Acute Branch Retinal Vein Occlusion

K. Eibenberger; S. Sacu; G. Matt; W. Buehl; R. Dunavoelgyi; C. Pruente; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4736. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of Foveal Sparing in Geographic Atrophy in Fundus Autofluorescence and Spectral-Domain Optical Coherence Tomography

U. W. Scheschy; R. G. Sayegh; C. Simader; C. G. Kiss; M. Baratsits; S. Sacu; C. Pruente; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):311. doi:

ARVO Annual Meeting Abstract April 2010

Comparison of Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence in Patients With Geographic Atrophy

R. G. Sayegh; C. Simader; U. Scheschy; A. Montuoro; C. G. Kiss; S. Sacu; D. Kreil; C. Pruente; U. Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):312. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Radial foveal incisions as a surgical technique for persistent macula holes

Microvascular abnormalities, retinal thickness changes and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD

Early retinal changes in Optical Coherence Tomography in patients with type 1 diabetes under intensified insulin therapy

Correlation of total HbA1c load with prevalence of diabetic retinopathy among type 1 diabetic patients treated with intensified insulin therapy from the onset of disease

Low energy stereotactic radiotherapy in combination with an anti VEGF treat and extend regimen for treatment of neovascular age related macular degeneration: 12 month outcomes

A cross sectional study assessing the prevalence of different stages of diabetic retinopathy and diabetic macular edema among type 1 diabetic patients treated with long-term intensified insulin therapy aiming near-normal blood glucose levels

Assessment of drusen and other retinal degenerative changes in patients with hereditary hemochromatosis

Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial

Efficacy and safety of ranibizumab in two treat-and-extend versus pro-re-nata regimes in patients with visual impairment due to diabetic macular edema: 24-month results of RETAIN study

Treat and Extend regimen versus Pro Re Nata regimen in a comparative study of ranibizumab in exudative age-related macular degeneration: 12 months results

Changing from pro re nata treatment regimen to a treat and extend regimen in neovascular age-related macular degeneration

Prevalence Of Polypoidal Choroidal Vasculopathy Among Caucasian Bad-responders To Antivegf-treatment In Exudative Amd

Response of Retinal Vessels and Retrobulbar Hemodynamics to Intravitreal Anti-VEGF Treatment in Eyes with Branch Retinal Vein Occlusion

Effect of Intravitreal Anti-VEGF Therapy to Retinal Nonperfusion in Patients treated with Lucentis (Ranibizumab) for Retinal Vein Occlusion

Effect of Systemic Steroid after Successful Macular Surgery in Eyes with Epiretinal Membrane : Long Term Results of a Randomized Study

Ranibizumab Treatment for Diabetic Macular Edema in a Clinical Routine Setting: 12 Months Results

Response of Retinal Vessels to Anti Vascular Endothelial Growth Factor Treatment in Patients With Branch Retinal Vein Occlusion

Intravitreal Ranibizumab for the Treatment of Significant Macular Edema Secondary to Acute Branch Retinal Vein Occlusion

Evaluation of Foveal Sparing in Geographic Atrophy in Fundus Autofluorescence and Spectral-Domain Optical Coherence Tomography

Comparison of Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence in Patients With Geographic Atrophy

To View More...

You must be signed into an individual account to use this feature.